Dexmedetomidine could reduce the incidence of cognitive impairment after intestinal I/R injury, which may be related to decreased levels of inflammatory cytokines IL-1β, IL-6, C-reactive protein, and TNF-α [45]. The gene discussed is TNF; the disease is Cognitive impairment.